MedPath

Samsung Medical Center

Samsung Medical Center logo
πŸ‡°πŸ‡·South Korea
Ownership
Subsidiary
Established
1994-01-01
Employees
501
Market Cap
-
Website
http://www.samsunghospital.com

Genomic Profiling of Pancreatic Cystic Tumors

Not yet recruiting
Conditions
Pancreatic Cyst
First Posted Date
2024-01-08
Last Posted Date
2024-01-08
Lead Sponsor
Samsung Medical Center
Target Recruit Count
250
Registration Number
NCT06195904
Locations
πŸ‡°πŸ‡·

Samsung Medical Center, Seoul, Korea, Republic of

πŸ‡°πŸ‡·

Seoul St. Mary's Hospital, Seoul, Korea, Republic of

Tele-education in Ultrasound Training

Not Applicable
Completed
Conditions
Education, Medical, Continuing
Telemedicine
Ultrasonography
Interventions
Device: Head-Mounted Display (HMD) to communicate with a supervisor remotely
First Posted Date
2023-12-15
Last Posted Date
2025-01-03
Lead Sponsor
Samsung Medical Center
Target Recruit Count
40
Registration Number
NCT06171828
Locations
πŸ‡°πŸ‡·

Samsung Medical Center, Seoul, Korea, Republic of

Remimazolam vs. Propofol: Impact on Postoperative Delirium in Neurosurgical Patients

Not Applicable
Recruiting
Conditions
Postoperative Delirium
Interventions
First Posted Date
2023-11-02
Last Posted Date
2024-04-17
Lead Sponsor
Samsung Medical Center
Target Recruit Count
696
Registration Number
NCT06115031
Locations
πŸ‡°πŸ‡·

Samsung Medical Center, Seoul, Korea, Republic of

Lazertinib & Tepotinib for EGFR Mutant NSCLC in MET Overexpressed or Amplified Who Progressed After Lazertinib Treatment

Phase 2
Not yet recruiting
Conditions
Non-Small Cell Lung Cancer Metastatic
Interventions
First Posted Date
2023-10-30
Last Posted Date
2023-10-30
Lead Sponsor
Samsung Medical Center
Target Recruit Count
47
Registration Number
NCT06106802
Locations
πŸ‡°πŸ‡·

Samsung Medical Center, Seoul, Gangnam-gu, Korea, Republic of

Modulating Surgery-Induced Blood-Brain Barrier Disruption in Elderly

Not Applicable
Recruiting
Conditions
Delirium, Postoperative
Interventions
First Posted Date
2023-10-19
Last Posted Date
2024-04-17
Lead Sponsor
Samsung Medical Center
Target Recruit Count
108
Registration Number
NCT06090955
Locations
πŸ‡°πŸ‡·

Samsung Medical Center, Seoul, Korea, Republic of

Haploidentical Hematopoietic Stem Cell Transplantation With Early ATG and Low Dose Post-transplant Cyclophosphamide

Recruiting
Conditions
Haploidentical Hematopoietic Stem Cell Transplantation
Interventions
Drug: ATG-LDPTCy
First Posted Date
2023-09-18
Last Posted Date
2024-12-03
Lead Sponsor
Samsung Medical Center
Target Recruit Count
20
Registration Number
NCT06041893
Locations
πŸ‡°πŸ‡·

Samsung Medical Center, Seoul, Korea, Republic of

An Open Label Phase II Study of First-Line Maintenance Enzalutamide Following Docetaxel Plus Androgen-Deprivation Therapy in Patients With Previously-Untreated, Metastatic, Castration-Naive Prostatic Adenocarcinoma

Phase 2
Not yet recruiting
Conditions
Prostatic Adenocarcinoma
Interventions
First Posted Date
2023-08-29
Last Posted Date
2023-08-29
Lead Sponsor
Samsung Medical Center
Target Recruit Count
51
Registration Number
NCT06015321
Locations
πŸ‡°πŸ‡·

Samsung Medical Center, Seoul, Korea, Korea, Republic of

Mobile Chat Service for Parents of Children in Pediatric Emergency Room

Not Applicable
Recruiting
Conditions
Medical Informatics
Emergency Medicine
Pediatric Emergency Medicine
Interventions
Behavioral: Control
Behavioral: Information provided
First Posted Date
2023-08-21
Last Posted Date
2023-08-21
Lead Sponsor
Samsung Medical Center
Target Recruit Count
60
Registration Number
NCT06002542
Locations
πŸ‡°πŸ‡·

Samsung Medical Center, Seoul, Gangnam, Korea, Republic of

Comparison Physiological Effects According to Preoxygenation Method Using EIT

Not Applicable
Withdrawn
Conditions
Acute Hypoxemic Respiratory Failure
Interventions
Device: HFNC
First Posted Date
2023-07-27
Last Posted Date
2024-04-17
Lead Sponsor
Samsung Medical Center
Registration Number
NCT05962073
Locations
πŸ‡°πŸ‡·

Samsung Medical Center, Seoul, Gangnam, Korea, Republic of

Exosome as the Prognostic and Predictive Biomarker in EBC Patients

Not Applicable
Active, not recruiting
Conditions
HER2-positive Breast Cancer
Triple Negative Breast Cancer
Interventions
Procedure: exosome and ctDNA evaluation
First Posted Date
2023-07-21
Last Posted Date
2023-07-21
Lead Sponsor
Samsung Medical Center
Target Recruit Count
200
Registration Number
NCT05955521
Locations
πŸ‡°πŸ‡·

Ji-Yeon Kim, Seoul, Korea, Republic of

Β© Copyright 2025. All Rights Reserved by MedPath